183 related articles for article (PubMed ID: 14736880)
1. Flexible N-terminal region of prion protein influences conformation of protease-resistant prion protein isoforms associated with cross-species scrapie infection in vivo and in vitro.
Lawson VA; Priola SA; Meade-White K; Lawson M; Chesebro B
J Biol Chem; 2004 Apr; 279(14):13689-95. PubMed ID: 14736880
[TBL] [Abstract][Full Text] [Related]
2. N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro.
Lawson VA; Priola SA; Wehrly K; Chesebro B
J Biol Chem; 2001 Sep; 276(38):35265-71. PubMed ID: 11466311
[TBL] [Abstract][Full Text] [Related]
3. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier.
Kocisko DA; Priola SA; Raymond GJ; Chesebro B; Lansbury PT; Caughey B
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3923-7. PubMed ID: 7732006
[TBL] [Abstract][Full Text] [Related]
4. Formation of protease-resistant prion protein in cell-free systems.
Caughey B
Curr Issues Mol Biol; 2000 Jul; 2(3):95-101. PubMed ID: 11471561
[TBL] [Abstract][Full Text] [Related]
5. Acute cellular uptake of abnormal prion protein is cell type and scrapie-strain independent.
Greil CS; Vorberg IM; Ward AE; Meade-White KD; Harris DA; Priola SA
Virology; 2008 Sep; 379(2):284-93. PubMed ID: 18692214
[TBL] [Abstract][Full Text] [Related]
6. Prion seeding activities of mouse scrapie strains with divergent PrPSc protease sensitivities and amyloid plaque content using RT-QuIC and eQuIC.
Vascellari S; Orrù CD; Hughson AG; King D; Barron R; Wilham JM; Baron GS; Race B; Pani A; Caughey B
PLoS One; 2012; 7(11):e48969. PubMed ID: 23139828
[TBL] [Abstract][Full Text] [Related]
7. Species-independent inhibition of abnormal prion protein (PrP) formation by a peptide containing a conserved PrP sequence.
Chabry J; Priola SA; Wehrly K; Nishio J; Hope J; Chesebro B
J Virol; 1999 Aug; 73(8):6245-50. PubMed ID: 10400714
[TBL] [Abstract][Full Text] [Related]
8. A 60-kDa prion protein (PrP) with properties of both the normal and scrapie-associated forms of PrP.
Priola SA; Caughey B; Wehrly K; Chesebro B
J Biol Chem; 1995 Feb; 270(7):3299-305. PubMed ID: 7852415
[TBL] [Abstract][Full Text] [Related]
9. A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells.
Priola SA; Chesebro B
J Virol; 1995 Dec; 69(12):7754-8. PubMed ID: 7494285
[TBL] [Abstract][Full Text] [Related]
10. Protein Misfolding Cyclic Amplification Cross-Species Products of Mouse-Adapted Scrapie Strain 139A and Hamster-Adapted Scrapie Strain 263K with Brain and Muscle Tissues of Opposite Animals Generate Infectious Prions.
Gao C; Han J; Zhang J; Wei J; Zhang BY; Tian C; Zhang J; Shi Q; Dong XP
Mol Neurobiol; 2017 Jul; 54(5):3771-3782. PubMed ID: 27259989
[TBL] [Abstract][Full Text] [Related]
11. High-resolution differentiation of transmissible spongiform encephalopathy strains by quantitative N-terminal amino acid profiling (N-TAAP) of PK-digested abnormal prion protein.
Gielbert A; Davis LA; Sayers AR; Hope J; Gill AC; Sauer MJ
J Mass Spectrom; 2009 Mar; 44(3):384-96. PubMed ID: 19053160
[TBL] [Abstract][Full Text] [Related]
12. In situ formation of protease-resistant prion protein in transmissible spongiform encephalopathy-infected brain slices.
Bessen RA; Raymond GJ; Caughey B
J Biol Chem; 1997 Jun; 272(24):15227-31. PubMed ID: 9182546
[TBL] [Abstract][Full Text] [Related]
13. Prion protein and species barriers in the transmissible spongiform encephalopathies.
Priola SA
Biomed Pharmacother; 1999; 53(1):27-33. PubMed ID: 10221165
[TBL] [Abstract][Full Text] [Related]
14. Transmissible spongiform encephalopathy strain-associated diversity of N-terminal proteinase K cleavage sites of PrP(Sc) from scrapie-infected and bovine spongiform encephalopathy-infected mice.
Howells LC; Anderson S; Coldham NG; Sauer MJ
Biomarkers; 2008 Jun; 13(4):393-412. PubMed ID: 18484354
[TBL] [Abstract][Full Text] [Related]
15. Prions of ruminants show distinct splenotropisms in an ovine transgenic mouse model.
Baron T; Bencsik A; Morignat E
PLoS One; 2010 Apr; 5(4):e10310. PubMed ID: 20436680
[TBL] [Abstract][Full Text] [Related]
16. Scrapie-associated PrP accumulation and agent replication: effects of sulphated glycosaminoglycan analogues.
Caughey B
Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):399-404. PubMed ID: 7913757
[TBL] [Abstract][Full Text] [Related]
17. Glycosylation influences cross-species formation of protease-resistant prion protein.
Priola SA; Lawson VA
EMBO J; 2001 Dec; 20(23):6692-9. PubMed ID: 11726505
[TBL] [Abstract][Full Text] [Related]
18. N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state.
Caughey B; Raymond GJ; Ernst D; Race RE
J Virol; 1991 Dec; 65(12):6597-603. PubMed ID: 1682507
[TBL] [Abstract][Full Text] [Related]
19. Methods for studying prion protein (PrP) metabolism and the formation of protease-resistant PrP in cell culture and cell-free systems. An update.
Caughey B; Raymond GJ; Priola SA; Kocisko DA; Race RE; Bessen RA; Lansbury PT; Chesebro B
Mol Biotechnol; 1999 Nov; 13(1):45-55. PubMed ID: 10934521
[TBL] [Abstract][Full Text] [Related]
20. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans.
Raymond GJ; Hope J; Kocisko DA; Priola SA; Raymond LD; Bossers A; Ironside J; Will RG; Chen SG; Petersen RB; Gambetti P; Rubenstein R; Smits MA; Lansbury PT; Caughey B
Nature; 1997 Jul; 388(6639):285-8. PubMed ID: 9230438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
